搜索结果

Search Results for " glucosylceramide synthase (gcs) "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
TQ0155	Miglustat hydrochloride NB-DNJ hydrochloride,盐酸美格鲁特,N-Butyldeoxynojirimycin hydrochloride,OGT918 hydrochloride	Transferase	Metabolism
	Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) 是一种葡萄糖神经酰胺合酶抑制剂，可用于 I 型戈谢病的相关研究。
T4473	Ibiglustat Venglustat,SAR402671,GZ402671	Transferase	Metabolism
	Ibiglustat (GZ402671) 是一种可透过血脑屏障的、具有口服活性的葡萄糖神经酰胺合成酶(GCS)抑制剂。它可用于戈谢病 3 型、法布瑞氏症、与 GBA 突变相关的帕金森病、GM2 神经节苷脂病和常染色体显性多囊肾病的研究。
T3663	Eliglustat GENZ-112638,Genz 99067,依利格鲁司特	Transferase	Metabolism
	Eliglustat (Genz 99067) 是一种高效的、特异性的、有口服活性的葡糖脑苷脂合成酶抑制剂(IC50:24 nM)。
T62898	Glucosylceramide synthase-IN-1
	Glucosylceramide synthase-IN-1 (T-036) 是一种有效的、口服具有活力的、具有血脑屏障通透性的 glucosylceramide synthase (GCS) 抑制剂，作用于人 GCS (IC50: 31 nM) 和小鼠 GCS (IC50: 51 nM)。Glucosylceramide synthase-IN-1 能够用于研究戈谢病。
T70685	CCG-203586
	CCG-203586 is a novel potent glucosylceramide synthase (GCS) inhibitor.
T61632	Glucosylceramide synthase-IN-3
	Glucosylceramide synthase-IN-3 (compound BZ1) is a highly potent, brain-penetrant, and orally active inhibitor of glucosylceramide synthase (GCS), exhibiting an IC50 value of 16 nM for human GCS. This compound, designated as Glucosylceramide synthase-IN-3, finds potential applications in Gaucher's disease research [1] [2].
T62664	Glucosylceramide synthase-IN-2
	Glucosylceramide synthase-IN-2 (compound T-690) 是一种有效的、具有血脑屏障通透性的、口服具有活力的 glucosylceramide synthase (GCS) 抑制剂，作用于人 GCS (IC50: 15 nM) 和小鼠 GCS (IC50: 190 nM)。Glucosylceramide synthase-IN-2 能够非竞争性抑制 C8 神经酰胺和 UDP 葡萄糖。Glucosylceramide synthase-IN-2 能够用于研究戈谢病。
T70336	Nizubaglustat
	Nizubaglustat为一种针对神经酰胺葡萄糖基转移酶或葡萄糖神经酰胺合酶(GCS)的抑制剂，同时也能抑制GBA2，后者与神经病理学溶酶体贮积症相关。
T39105	Ibiglustat succinate GZ402671succinate,Venglustat succinate,Ibiglustat succinate,SAR402671succinate
	Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant inhibitor of glucosylceramide synthase (GCS). It is utilized in the investigation of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease.